Word

Status

Pending

Status Code

630

Status Date

Thursday, March 14, 2024

Serial Number

79391354

Mark Type

5

Filing Date

Friday, December 22, 2023

Trademark Owner History

Genexine, Inc.

Classifications

5 Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment; biological preparations for medical purposes; cardiovascular agents for medical purposes; drugs for medical purposes; synthetic peptides for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; anemia treatment medicines that stimulate red blood cell production; medicines to stimulate red blood cell production; medicines for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes; synthetic peptides for pharmaceutical and anemia treatment purposes; synthetic peptides for pharmaceutical and kidney disease treatment purposes.

Trademark Events

Mar 14, 2024

Sn Assigned For Sect 66a Appl From Ib

Mar 22, 2024

New Application Office Supplied Data Entered

Apr 24, 2024

Application Filing Receipt Mailed